Ohcanbohtosat - Julie Birt
- Čájehuvvo 1 - 2 / 2
-
1
Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA Dahkki Andrew Blauvelt, Alyssa Garrelts, William Malatestinic, Julie Birt, Baojin Zhu, Meghan Feely
Almmustuhtton 2023Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
2
Six-Month Real-World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry Dahkki Mark Lebwohl, Bruce Strober, Amy Schrader, Alvin H. Li, Thomas Eckmann, Baojin Zhu, William N. Malatestinic, Julie Birt, Meghan Feely, Andrew Blauvelt
Almmustuhtton 2024Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji